title: Axonal transport of AAV9 in nonhuman primate brain.
abstract: A pilot study in nonhuman primates was conducted, in which two Rhesus macaques received bilateral parenchymal infusions of adeno-associated virus serotype 9 encoding green fluorescent protein (AAV9-GFP) into each putamen. The post-surgical in-life was restricted to 3 weeks in order to minimize immunotoxicity expected to arise from expression of GFP in antigen-presenting cells. Three main findings emerged from this work. First, the volume over which AAV9 expression was distributed (Ve) was substantially greater than the volume of distribution of MRI signal (Vd). This stands in contrast with Ve/Vd ratio of rAAV2, which is lower under similar conditions. Second, post-mortem analysis revealed expression of GFP in thalamic and cortical neurons as well as dopaminergic neurons projecting from substantia nigra pars compacta, indicating retrograde transport of AAV9. However, fibers in the substantia nigra pars reticulata, a region that receives projections from putamen, also stained for GFP, indicating anterograde transport of AAV9 as well. Finally, one hemisphere received a 10-fold lower dose of vector compared with the contralateral hemisphere (1.5 × 10(13) vg ml(-1)) and we observed a much stronger dose effect on anterograde-linked than on retrograde-linked structures. These data suggest that AAV9 can be axonally transported bi-directionally in the primate brain. This has obvious implications to the clinical developing of therapies for neurological disorders like Huntington's or Alzheimer's diseases.
authors.affiliation: Department of Neurological Surgery, University of California-San Francisco, San Francisco, CA, USA.
authors.forename: F
authors.initials: F
authors.lastname: Green
authors.affiliation: Department of Neurological Surgery, University of California-San Francisco, San Francisco, CA, USA.
authors.forename: L
authors.identifier: 0000-0001-8151-473X
authors.initials: L
authors.lastname: Samaranch
authors.affiliation: Sangamo Biosciences Inc., Point Richmond Tech Center I, Richmond, CA, USA.
authors.forename: H S
authors.initials: HS
authors.lastname: Zhang
authors.affiliation: Sangamo Biosciences Inc., Point Richmond Tech Center I, Richmond, CA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Manning-Bog
authors.affiliation: Sangamo Biosciences Inc., Point Richmond Tech Center I, Richmond, CA, USA.
authors.forename: K
authors.initials: K
authors.lastname: Meyer
authors.affiliation: Department of Neurological Surgery, University of California-San Francisco, San Francisco, CA, USA.
authors.forename: J
authors.initials: J
authors.lastname: Forsayeth
authors.affiliation: Department of Neurological Surgery, University of California-San Francisco, San Francisco, CA, USA.
authors.forename: K S
authors.initials: KS
authors.lastname: Bankiewicz
mesh_terms: D000818:Animals; D000938:Antigen-Presenting Cells / Q000378:metabolism; D001253:Astrocytes / Q000378:metabolism / Q000821:virology; D001370:Axonal Transport / Q000235:genetics / Q000502:physiology*; D001921:Brain / Q000378:metabolism / Q000821:virology*; D003342:Corpus Striatum / Q000378:metabolism / Q000821:virology; D000229:Dependovirus / Q000235:genetics / Q000378:metabolism*; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000235:genetics; D049452:Green Fluorescent Proteins / Q000096:biosynthesis / Q000235:genetics; D008253:Macaca mulatta; D017628:Microglia / Q000378:metabolism / Q000821:virology; D009474:Neurons / Q000378:metabolism / Q000821:virology; D010865:Pilot Projects; D011699:Putamen / Q000378:metabolism / Q000821:virology; D013378:Substantia Nigra / Q000378:metabolism / Q000821:virology; D014161:Transduction, Genetic / Q000379:methods*
chemical_list: D049452:Green Fluorescent Proteins